Type 2 Diabetes Mellitus Completed Phase 3 Trials for Dulaglutide (DB09045)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus´╝îType 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01621178A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)Treatment
NCT01624259A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesTreatment
NCT02787551Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodTreatment
NCT01648582A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusTreatment
NCT01644500A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusTreatment
NCT02597049A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusTreatment
NCT01468181A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusTreatment
NCT01558271A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusTreatment
NCT01584232A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusTreatment
NCT01769378Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)Treatment
NCT03015220Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 DiabetesTreatment
NCT02648204Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.Treatment
NCT01394952Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)Treatment
NCT01064687A Study in Participants With Type 2 Diabetes MellitusTreatment
NCT01191268A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)Treatment
NCT02152371A Study of Dulaglutide (LY2189265) in Participants With Type II DiabetesTreatment
NCT01075282A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)Treatment
NCT01126580A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)Treatment